| AHP | accountable health plan or partnership; acute hemorrhagic pancreatitis; after hyperpolarization; air... |
|---|---|
| ANP | acute necrotizing pancreatitis; adult nurse practitioner; ancillary nursing personnel; A-norprogeste... |
| AP | accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p... |
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| CCP | cephalin-cholesterol flocculation; ciliocytophthoria; chronic calcifying pancreatitis; community car... |
| mumps orchitis | <pathology> A mumps infection that has affected the testicles. Approximately 20-35% of postpubertal males with mumps will develop this complication. (27 Sep 1997) |
|---|---|
| mumps sensitivity test | A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen. (05 Mar 2000) |
| mumps skin test antigen | A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure. (05 Mar 2000) |
| mumps vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunised with live mumps vaccine. Children are usually immunised with measles-mumps-rubella combinatiom vaccine. (12 Dec 1998) |
| mumps virus | The type species of rubulavirus that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection. (12 Dec 1998) |
| mumps virus vaccine | Vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| immunization, mumps | See Immunization, MMR. (12 Dec 1998) |